Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Policybazaar Group...

    Policybazaar Group injects Rs 362 Crore in docprime.com

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-09-18T13:49:50+05:30  |  Updated On 13 Aug 2021 3:06 PM IST

    DocPrime is a new venture by the PolicyBazaar Group that owns India's leading insurance brand PolicyBazaar.com and top fintech marketplace PaisaBazaar.com.


    New Delhi: docprime.com, the latest healthcare venture by Policybazaar Group, said it has received an initial internal funding of USD 50 million (about Rs 362 crore) from the parent company. Docprime.com, which allows users to book appointments with doctors and labs through its platform, has partnered up with 14,000 doctors and 5,000 diagnostic labs. It aims to expand its network to 1.50 lakh doctors and 20,000 labs across over 100 cities.


    DocPrime is a new venture by the PolicyBazaar Group that owns India's leading insurance brand PolicyBazaar.com and top fintech marketplace PaisaBazaar.com. Our mission is to redefine healthcare in India and deliver quality services to help people live healthier and happier lives.


    While docprime.com allows users to book appointments in Delhi-NCR, it also plans to make the facility available across all major cities, including Mumbai, Bangalore, Hyderabad and Chennai, the company said in a statement.


    "We intend to use the capital in providing seamless user experience and bringing innovation in the healthcare space. Our focus is to make the services more customer-friendly driven by transparency, trust, and sustainability," docprime.com CEO Ashish Gupta said.

    He added that the company is bringing in innovation through the use of various new-age technology tools like artificial intelligence (AI), data science and deep analytics.

    "Healthcare sector has a lot of untapped potentials and currently, the services are not affordable and accessible for all. With rising out-of-pocket expenses, there's a need to provide quality healthcare at competitive prices that can be accessed by anyone, anywhere," Yashish Dahiya, CEO and co-founder of Policybazaar Group of Companies, said.

    It also plans to bring in an OPD subscription-based product, which will cover unlimited consultations and diagnostic tests. The company is targeting 1 million free medical consultations by March 2019 and up to 5 million by March 2020.

    Earlier this year, Policybazaar had received a USD 238 million funding, led by Japan's SoftBank Group and its existing investors.
    AIartificial intelligenceAshish GuptaBangalorebook appointmentsChennaiDocPrimedocprime.comHealthcarehealthcare ventureHyderabadJapanmedical insuranceMumbaiOPD subscriptionPaisaBazaar.compolicy bazaar docprimePolicybazaarSoftBank GroupYashish Dahiya
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok